Deepmedchem
Founded 2023 · 10 employees on LinkedIn · 1 known investors
Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises. It serves pharmaceutical and biotech drug discovery teams and is a spin-off from The MAMA AI and i&i Prague connected to the IOCB medicinal chemistry institute in Europe.
Founders & leadership
JM
Jan MacekChief Executive Officer
ML
Miroslav LžičařChief Technical Officer
JR
Investors · 1
Frequently asked questions
- What does Deepmedchem do?
- Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises. It serves pharmaceutical and biotech drug discovery teams and is a spin-off from The MAMA AI and i&i Prague connected to the IOCB medicinal chemistry institute in Europe.
- Who are Deepmedchem's investors?
- Deepmedchem's investors include Biotech Investments S.R.O.